ArticleOncology letters2025

Multidisciplinary strategies including local treatment to achieve drug-free status after atezolizumab plus bevacizumab treatment in hepatocellular carcinoma.

Nobuaki Ishihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.